New research out of Texas could go a long way toward improving care for patients with acute decompensated heart failure.

The FDA’s final decision was based largely on positive results from the ADVENT clinical trial, which compared treatment with the Farapulse PFA System to the current standard of care.

Eckert & Ziegler and Nucleus RadioPharma have signed an agreement to address the increasing demand for Lu-177 and Ac-225.

Conversations last 10 minutes or less, with specialists providing a preliminary interpretation of imaging findings in conjunction with smoking cessation counseling. 

The University of Oklahoma Health has earned a $3 million grant from the National Cancer Institute for this project.

Annual SAVR volumes in the United States decreased by a whopping 44.5% from 2012 to 2022. However, heart teams across the country seem to agree that surgery is a safer, more effective treatment option than TAVR when patients present with bicuspid aortic valves. 

Injuries to the esophagus remain a common complication associated with radiofrequency ablation procedures. New research suggests a device developed by S4 Medical could significantly reduce the risk of such injuries. 

This includes elevated diagnosis rates for non-Hispanic Black women in their 20s and 30s, before regular mammography screening starts.